We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

DIAGNOSTICA STAGO

Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routin... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Automated Hemostasis Tests Affected By Hemolysis, Icterus And Lipemia

By LabMedica International staff writers
Posted on 02 Aug 2016
Print article
Image: The STA-Compact-Max viscosity-based detection coagulation analyzer (Photo courtesy of Stago).
Image: The STA-Compact-Max viscosity-based detection coagulation analyzer (Photo courtesy of Stago).
Laboratory diagnosis is more and more prominent in modern medicine and it is commonly accepted that approximately 70% of all medical decisions are based on the laboratory results and accurate results are therefore key for appropriate diagnosis.

One of the requirements for a clinical laboratory is that common interferences related to sample integrity such as hemolysis, icterus and lipemia (HIL) be evaluated with each reagent system and because of limited resources and budgetary constraints, the clinical laboratory relies on the manufacturer to document HIL estimates.

Scientists at the Royal Hallamshire Hospital (Sheffield, UK) and their French colleagues collected blood samples for testing plasma-based coagulation assays and molecular hemostasis assays. They assessed the influence of HIL on prothrombin time (PT), activated partial thromboplastin time (APTT) and fibrinogen assay using a viscosity-based detection analyzer (VBDS). Interference of hemolysis was studied in two different ways: spontaneous in vitro hemolysis judged to have occurred during sample collection transport or processing and spurious hemolysis.

The level of hemolysis was semi-quantitatively estimated based on the measurement of hemoglobin concentration using a XN-10 (Sysmex Corporation, Kobe, Japan). All the coagulation assays were performed using reagents and a STA-Compact-Max analyzer (Stago, Asnières sur Seine, France). One reagent, Stago’s STA-Liquid Fib, titrated human calcium thrombin, was used for the measurement of fibrinogen.

The scientists found that spontaneous hemolysis that occurred during sample collection and processing had no effect on PT with either a rabbit tissue factor extract or recombinant human tissue factor reagents. In contrast, addition of mechanically hemolysis cells impacted on PT for the highest hemoglobin concentration. For APTTs there was no significant difference between results in hemolysed and nonhemolysed samples. For the other two reagents studied, APTTs were statistically significantly shorter in hemolysed samples compared with nonhemolysed samples. This bias was clinically significant only for STA-PTT Automate reagent. For all three APTT reagents, the impact of hemolysis was sufficient to impact patient management decisions, and in some samples, the effects of lipemia and icterus were not clinically significant.

The authors concluded that their results confirm that PT and fibrinogen are not clinically significantly affected by HIL. The APTTs of some haemolysed samples were falsely normal with one reagent and more affected than two others. Hemolysed samples should be continuously rejected. Conversely, from a clinical standpoint, lipemia and icterus did not significantly affect APTT measured with the different reagents tested in combination with a VBDS analyzer.

Related Links:
Royal Hallamshire Hospital
Sysmex
Stago

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.